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1. Introduction
For several decades, the haematogenous spread of bacteria from the oral cavity has been
considered a decisive factor in the pathogenesis of 10% to 15% of episodes of infective
endocarditis (IE), suggesting that certain dental procedures may represent a significant risk
factor [1]. Nowadays, however, this statement has its detractors; their main argument is that
not all patients with heart valves infected by bacteria that typically colonize ecological niches
of the oral cavity have undergone dental procedures. Furthermore, there is little evidence to
date on the genetic similarity between bacteria isolated from the heart valves, from the
bloodstream, and from the oral cavity of patients with IE [2,3].
Apart from its possible involvement in the development of episodes of IE, bacteraemia of oral
origin has become of particular interest in the past 2 decades because it has been associated
with the progression of atherosclerosis and may thus be related to ischemic processes, although
the mechanism of action has not yet been fully elucidated [4-6]. A number of published clinical
studies have demonstrated an association between periodontal disease and cardiovascular
disease [7-9], and oral bacteria have been detected on heart valves and in atherosclerotic
plaques and aortic aneurysms [10-12].
In 1935, Okell and Elliot [13] were the first authors to detect bacteraemia caused by Strepto‐
coccus species (in 64% of cases) after performing dental extractions on 138 patients. A year later,
Burket and Burn [14] inoculated pigmented Serratia marcescens into the gingival sulcus of 90
patients before performing dental extractions and they subsequently isolated this bacterium
in 20% of post-manipulation blood cultures. Those results confirmed that microorganisms
from the oral cavity could enter the bloodstream after dental extraction. Between the mid 1930s
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and the early 1950s, numerous studies were published on the prevalence of post-dental
extraction bacteraemia, with figures that varied between 2% and 83% [15-19]. In the early 1930s
there was a growing awareness of the need for IE prophylaxis in patients with valvular heart
disease undergoing certain dental manipulations, and the first guidelines recommending the
use of certain sulfonamides to prevent IE of oral origin were published at the end of that decade.
This chapter first provides a review of development of antimicrobial prophylaxis protocols for
IE secondary to dental procedures between 1930 and 1955. Since the American Heart Associ‐
ation (AHA) published its first guideline for the prevention of IE secondary to dental proce‐
dures in 1955, several international committees formed mainly of cardiologists, infectious
diseases specialists and pharmacologists have drawn up different prophylactic regimens based
on findings published in the scientific literature. In the second part of this chapter we therefore
review the changes in IE prophylaxis in the guidelines published by the AHA and the British
Society of Antimicrobial Chemotherapy (BSAC) between 1960 and 2009, as well as those
recently drawn up by other societies. Those guidelines provide a description of the susceptible
patient, the at-risk dental procedures, the influence of the anaesthetic technique applied in
dental treatment, the antibiotic prophylaxis protocols (antibiotics of choice, dose and route of
administration) and the use of antiseptic prophylaxis.
2. Development of antimicrobial prophylaxis protocols for infective
endocarditis secondary to dental procedures: 1930 to 1955
In the early 1930s, Brown and Abrahamson [20,21] were 2 of the pioneers of the application of
IE prophylaxis before performing certain dental manipulations in patients with valvular heart
disease. Those investigators recommended the prophylactic use of autogenous vaccines. In
1938, Feldman and Trace [22] suggested cleaning and scraping the teeth before any manipu‐
lation in order to reduce contamination of the operative field; they performed only 1 or 2 dental
extractions per session, and followed this by curettage and irrigation of the periodontal pockets
with antiseptics. A year later, Elliott [23] proposed perialveolar cauterization of the gingiva as
a prophylactic measure after dental extraction; this technique not only sterilized the sulcus but
also sealed the gingival capillaries, preventing the entry of microorganisms into the blood‐
stream. The practice of dental extractions under local anaesthesia with epinephrine by the
infiltration technique was also recommended, as some authors had shown that this type of
anaesthetic applied in this way created a barrier, preventing vascular invasion by the bacterial
inoculum [14,22]. Fish and Maclean [24] recommended that teeth be filled with cotton soaked
in a paste of zinc oxide and oil of cloves and that this should be renewed every few days; those
authors also recommended the administration of a dose of prontosil (azosulfamide) before a
dental extraction, in addition to cauterization of the gingiva. However, Bender and Pressman
[17] soon declared themselves contrary to the use of cauterization to prevent post-dental
extraction bacteraemia, arguing that the teeth extracted in all the published series in which this
technique was used were single rooted and a maximum of only 2 teeth were extracted in each
session. According to those authors, cauterization of multirooted teeth damaged the adjacent
periodontal tissues [17].
Recent Advances in Infective Endocarditis54
The first guideline for antibiotic prophylaxis for IE associated with dental manipulations in
patients with valvular heart disease were soon developed and were based on the use of certain
sulfonamides [25,26]. In 1939, Long and Bliss [27] published a book titled The Clinical and
Experimental Use of Sulfanilamide, Sulfapyridine and Allied Compounds, in which they recom‐
mended the prophylactic administration of sulfanilamide to patients with rheumatic heart
disease before performing dental extractions. In 1941, Kolmer and Tuft [28] drew up the most
complete prophylactic guidelines published up to that time; those authors did not favour
“massive dental extractions” and recommended not extracting more than 2 teeth in a single
session; they also recommended the use of an autogenous streptococcal vaccine obtained from
culture of the apical area of the first tooth extracted, which was to be administered before
extraction of the following tooth. On the matter of antibiotic prophylaxis, those investigators
proposed a regimen based on the use of 15 grains of sulfapyridine every 6 hours, starting 2
days before the manipulation and continuing for 2 or 3 days afterwards; they also endorsed
the protocol for the prolonged administration of sulfonamides −previously proposed by
Thomas et al [25]−for patients with acute rheumatic fever; that protocol consisted of the
administration of 10 grains of sulfanilamide twice a day for a period that ran from November
to June [28]. In 1941, Spink [29] indicated that sulfanilamide had to be administered between
8 and 12 hours before the dental manipulation in order to achieve a serum concentration of 7
mg/100 ml at the time of the manipulation. A year later, Budnitz et al [30] proposed a prophy‐
lactic protocol that consisted of an initial dose of 1 g of sulfapyridine followed by 0.5 g every
4 hours for 6 to 7 days, performing the dental extraction on the third or fourth day.
In 1943, Northrop and Crowley [31] were the first authors to evaluate the effect of the antibiotic
sulfathiazole on the prevalence of post-dental extraction bacteraemia; their study group was
formed of 73 patients who received 1 g of sulfathiazole every 4 hours, starting at 4 pm the day
before the dental treatment and finishing at 12 noon the day of the procedure, 1 to 2 hours
before the dental extraction. Blood samples were collected to perform the corresponding
cultures at baseline and at 10 seconds and 10 minutes after the manipulation. All the baseline
blood cultures and all those collected at 10 minutes after the dental extraction were negative,
both in the controls and in individuals receiving antibiotic prophylaxis; however, at 10 seconds
after the dental extraction, 13% of controls presented detectable bacteraemia compared to 4%
of those who received antibiotic therapy (with blood levels of sulfathiazole of at least 3
mg/100 ml). These authors therefore concluded that a serum concentration of sulfathiazole of
4-5 mg/100 ml was effective for the prevention of post-dental extraction bacteraemia [31]. A
year later, in the Journal of Oral Surgery, the same authors published another study based on
the administration of a single dose of 5 g of sulfathiazole 3 hours before the dental manipula‐
tion, observing a reduction in the percentage of post-dental extraction bacteraemia from 16%
to 4% [32]. Hopkins [16] and Budnitz et al [30], in their respective studies of patients at risk of
IE, administered sulfanilamide or sulfapyridine before dental extraction; in both series all the
post-dental extraction blood cultures were negative. In 1945, Bender and Pressman [17], in a
study of the prevalence of post-dental extraction bacteraemia, created 3 randomly assigned
study groups: a control group, a sulfanilamide group (this group was administered 4 doses of
1.35 g of the drug the previous day and 2 g 4 hours before the manipulation) and a cauterisation
group (cauterisation of the free gingival border and of the full depth of the pocket was
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performed after the dental extraction). The mean serum levels of sulfanilamide were 7.5
mg/100 ml. In contrast to the results reported previously by other authors [16], the adminis‐
tration of sulfanilamide in this study did not reduce the prevalence of immediate post-dental
extraction bacteraemia (83% in the control group versus 77% in the sulfanilamide group),
although there was a detectable reduction in the number of positive blood cultures at 10
minutes after completion of the manipulation (33% in the control group versus 13% in the
sulfanilamide group) and in the number of bacterial species isolated. Those authors indicated
that the good results reported previously in the literature could be attributable to the absence
of para-aminobenzoic acid (necessary to neutralise the sulfonamides) from the culture media
used in some studies and based their findings mainly on the bacteriostatic action of this group
of antibiotics [17].
In 1948, Hirsh et al [33] were the first authors to investigate the effect of penicillin on the
prevalence of post-dental extraction bacteraemia. The study population was composed of a
control group of 65 patients and a study group of 65 patients who received 600,000 IU of
penicillin intramuscularly 3 to 4 hours before the dental extraction. Blood samples were
collected immediately after the completion of surgery and at 10 and 30 minutes. Although the
overall percentage of bacteraemia did not decline significantly (46% in controls versus 37% in
the group that received penicillin), evaluation of only those cultures that were positive for
streptococcal species showed a significant reduction in the prevalence of positive cultures in
the group receiving prophylaxis compared to the control group (15% versus 34%), confirming
that penicillin was effective in reducing the prevalence of streptococcal bacteraemia, although
not bacteraemia caused by other microorganisms. Those authors speculated about 2 possible
mechanisms of action of penicillin in the prevention of bacteraemia secondary to dental
extractions: the first was that the penicillin present in the blood destroyed the microorganisms
that reached the bloodstream, and the second that the antibiotic could inhibit bacterial growth
in the oral cavity, thus reducing the size of the inoculum before vascular invasion occurred
[33]. In another study on the efficacy of penicillin in the prevention of post-dental extraction
bacteraemia published the same year, Glaser et al [34] administered 50,000 IU of penicillin
intramuscularly every 2 hours for 24 hours prior to dental extraction, administering the final
injection approximately 20 minutes before the manipulation. They then determined the
sensitivity to penicillin of the microorganisms isolated from the blood cultures of patients who
received the antibiotic therapy. In that study, prophylaxis with penicillin significantly reduced
the prevalence of post-dental extraction bacteraemia (by 25%), as well as the number of bacteria
isolated: there was a predominance of α-haemolytic streptococci in the control group (81%
versus 29% in the group that received penicillin) and the majority of streptococci isolated in
the penicillin group were non-haemolytic. However, none of the microorganisms isolated in
the subjects who received prophylaxis were resistant to penicillin, confirming that this was
not the cause of onset of the bacteraemia. Two very interesting findings of that study were that
prophylaxis with penicillin was more effective in patients with periodontal disease and in
those in whom only a single dental extraction was performed. Finally, those authors described
a third mechanism of action of penicillin in the prevention of IE, the inhibition of bacterial
growth after implantation of the microorganisms on the endocardium and before the resulting
disease became clinically detectable [34]. Rhoads and Schram [35] evaluated the efficacy of
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penicillin and a new sulfonamide, 3,4-dimethyl-5-sulfanilamidoisoxazole (Gantrosan), for the
prevention of post-dental extraction bacteraemia. Based on their optimal results, those authors
were emphatic in their indication of the need to administer antibiotic therapy prior to per‐
forming dental extractions in patients with valvular heart disease [35].
The book on oral surgery published by Thoma in 1948 [36] was the first to include antibiotic
prophylaxis prior to oral surgical procedures in patients with heart disease, although no
specific regimen was described. In the first edition of Archer’s classic book on oral surgery
published in 1952 [37], a complex prophylactic regimen was described based on the adminis‐
tration of an injection of procaine penicillin G the day before oral surgery and an injection of
crystalline penicillin G 30 minutes before the procedure, followed by an injection of procaine
penicillin G once a day for 3 days and an injection of bicillin together with the final injection
of procaine penicillin G. A very similar antibiotic prophylaxis regimen appeared in another
book on oral surgery published by Mead in 1954 [38], but the penicillin was limited to 3 doses:
one the day before, one 20 to 30 minutes before the manipulation and the final one the day
after the intervention.
In 1955, the Committee on Prevention of Rheumatic Fever and IE of the AHA, which at that
time was formed exclusively by 7 physicians, developed the first prophylactic protocol for use
in patients with IE undergoing dental procedures [39]. This protocol was recommended in
patients with congenital or rheumatic heart disease who were undergoing dental extractions
or other manipulations that affected the gingival tissues. The AHA experts stated that the aim
of prophylaxis was to make high concentrations of the antibiotic available at the time of the
manipulation and to maintain the presence of the drug in the bloodstream for several days in
order to eliminate any bacteria that had adhered to the heart valves during the bacteraemic
episode. The method chosen was an intramuscular injection of a dose of 600,000 IU of aqueous
penicillin and 600,000 IU of procaine penicillin dissolved in oil with 2% aluminium mono‐
stearate administered 30 minutes before the dental procedure. Alternatively (although less
desirable), they proposed the oral administration of 250,000-500,000 IU of penicillin 30 minutes
before each meal and before bedtime, starting 24 hours before the dental treatment and
continuing for 5 days afterwards, and with an extra dose of 250,000 IU of penicillin immediately
prior to the manipulation. For patients with a history of allergy to penicillin, the AHA
recommended the use of other antibiotics such as oxytetracycline, chlortetracycline or
erythromycin for 5 days, with administration starting the day before dental treatment [39].
3. Development of antimicrobial prophylaxis protocols for infective
endocarditis secondary to dental procedures: 1960 to 2009
Since the AHA published its first protocol for the prevention of IE associated with dental
procedures, numerous expert committees in different countries have drawn up different
prophylactic regimens, many of which have subsequently been revised and modified based
on subsequent epidemiological and clinical studies (prevalence of bacteraemia secondary to
dental procedures, studies of the efficacy of antibiotic and antiseptic prophylaxis, pharmaco‐
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kinetics of antibiotic prophylaxis, antimicrobial sensitivity of isolates identified in post-dental
manipulation blood cultures) and on animal experimentation [40].
The AHA has published 9 IE prophylaxis protocols, the latest revision being in 2007 [39,41-48].
The BSAC published its first antibiotic prophylaxis regimen for IE in 1982; this was revised
and modified in 1986, 1990, 1992 and 2006 [49-53]. The European Society of Cardiology (ESC),
together with the group of experts of the International Society of Chemotherapy published a
European Consensus on IE prophylaxis in 1995 [54]. In 2004, the ESC and the British Cardiac
Society (BCS), in association with the Royal College of Physicians (RCP) of London, drew up
guidelines for the prevention of IE associated with dental procedures [55,56]. In 2008, the
National Institute for Clinical Excellence (NICE) of the United Kingdom published clinical
guidelines entitled “Prophylaxis against IE: antimicrobial prophylaxis against IE in adults and
children undergoing interventional procedures” [57]. In that document, the NICE reviewed 4
clinical guidelines on the prevention of IE, including those published by the BSAC in 2006 and
the AHA in 2007. The NICE also reviewed the available evidence on the principal issues of IE
of oral origin and reported their conclusions. In 2009, the Task Force of the ESC published a
new guideline on the prevention, diagnosis and treatment of IE [58].
3.1. Susceptible patients
In its 2 protocols published in the 1960s on the prevention of IE associated with dental
procedures, the AHA defined subjects considered to be at risk of IE as those with rheumatic
heart disease or congenital heart disease [41,42]. In the early seventies, the AHA emphasised
that IE represented one of the most serious cardiac complications as it was associated with a
high morbidity and mortality, though it recognised that it was impossible to predict which
patients with cardiac abnormalities were susceptible to developing IE after interventions
(including those performed in the dental setting) [43]. However, they added patients with a
past history of IE, including those with no detectable cardiac abnormalities, to the list of
patients considered to be at risk of IE. For the first time, the AHA indicated that patients who
were candidates for cardiac surgery should undergo an exhaustive dental examination in order
to perform all necessary treatments in the weeks prior to the operation, with the aim of
reducing the risk of postoperative IE. After cardiac surgery, patients would remain indefinitely
in the category labelled at risk of IE (particularly those with prosthetic valves) and would
therefore be candidates for antibiotic prophylaxis. In the opinion of the AHA, patients with
atrial septal secundum defects repaired surgically by direct suturing, without the need for a
prosthetic patch, and patients who had undergone surgical repair of a patent ductus arteriosus
were not at risk of IE; in the AHA’s opinion, those patients would only need to receive antibiotic
prophylaxis for dental treatment performed during the first 6 months after cardiac surgery [43].
Five years later, in its new guideline, the AHA pointed out that, despite advances in antimicro‐
bial chemotherapy and cardiovascular surgery, IE continued to be associated with a signifi‐
cant morbidity and mortality [44]. For the first time, this Association listed those cardiac
alterations considered to carry a risk of IE and in which the administration of antibiotic
prophylaxis was indicated; the list included congenital heart disease, acquired valve disease
(rheumatic  fever),  idiopathic  hypertrophic  subaortic  stenosis,  mitral  valve  prolapse with
Recent Advances in Infective Endocarditis58
insufficiency and prosthetic valves, but not the presence of a secundum atrial septal defect. The
AHA stated that mitral valve prolapse was associated with a relatively low incidence of IE and
that the use of prophylaxis in these patients was therefore controversial. Antibiotic prophylax‐
is was not recommended for patients after coronary artery surgery, the insertion of pacemak‐
ers,  those  on  renal  dialysis  with  arteriovenous  fistulae  or  hydrocephalic  patients  with
ventriculoatrial shunts, although the it was added that “It will be the physician or dentist who takes
the final decision about whether the patient requires the administration of antibiotic prophylaxis” [44].
In the first BSAC guideline on the prevention of IE secondary to dental procedures, patients
considered to be at risk of IE included those with alterations of the endocardium due to
congenital or acquired disease, those with valvular heart disease and those with prosthetic
heart valves [49]. In 1984, the AHA stated that certain patients, such as those with prosthetic
heart valves or surgically constructed systemic-pulmonary shunts, presented a higher risk of
IE than patients with other heart conditions. This was the first guideline to include a discussion
of the action to be taken in patients who were anticoagulated with heparin or dicoumarin
derivatives, stating that the antibiotic prophylaxis should be administered intravenously or
orally, and that intramuscular injections should be avoided because of the risk of causing
haematomas [45].
In 1990, the AHA listed the heart conditions that did and did not require antibiotic prophylaxis
[46]. On the subject of heart transplant patients, the AHA briefly commented that some experts
considered these patients to be at risk of IE. In the case of patients with severe renal dysfunction,
it was suggested that the second dose of antibiotic (gentamycin or vancomycin) proposed in
some regimens should be omitted or modified [46]. Concerning the controversy over valve
prolapse, in 1990, the BSAC gave its first opinion in favour of prophylaxis in mitral valve
prolapse if the prolapse was associated with a systolic murmur [51].
The intense debate about IE prophylaxis that developed during the European Symposium held
in Lyon in 1994 led an international group of experts to draw up a consensus protocol jointly
with the Working Group on Valvular Heart Disease of the ESC [54]. The guideline was
published in 1995 and it listed the heart conditions that required prophylaxis, establishing for
the first time the conditions or diseases that were considered to carry a high risk of IE, such as
prosthetic heart valves, cyanotic congenital heart disease and previous episodes of IE. The
controversy concerning the administration of antibiotic prophylaxis in cases of mitral stenosis
without valve incompetence was also discussed [54].
In 1997, the AHA adopted a more conservative attitude, admitting that the incidence of IE
secondary to medico-surgical interventions in patients with cardiac abnormalities was low
[47]. It was suggested that the indication for antibiotic prophylaxis should be conditioned by
a number of factors such as the degree of risk of IE associated with the patient’s specific cardiac
abnormality, the probability that the procedure performed might cause bacteraemia, possible
adverse reactions to the recommended antibiotics and the cost-benefit relationship of the
prophylactic regimens. One of the important novelties introduced by the AHA was the
differentiation between cardiac diseases with distinct levels of risk of developing IE (as had
previously been done by the ESC in the European Consensus of 1995), and consideration of
the associated morbidity and mortality (Table 1) [47].
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PROPHYLAXIS RECOMMENDED PROPHYLAXIS NOT RECOMMENDED
HIGH RISK OF IE
-Valve prostheses
-Previous episodes of IE
-Cyanotic congenital heart diseasea
-Surgically constructed systemic-pulmonary shunts or
conduits
MODERATE RISK OF IE
-Structural heart defectsb
-Acquired valve disease (e.g. due to rheumatic disease)
-Hypertrophic obstructive cardiomyopathy
-Mitral valve prolapse with regurgitation and/or
thickened leaflets
LOW RISK OF IE
-Isolated secundum atrial septal defect
-Surgically repaired structural heart defects (after 6
months)c
-Previous coronary artery bypass graft surgery
-Physiological, functional or innocent heart murmursd
-History of Kawasaki’s disease without valve dysfunction
-History of rheumatic fever without valve dysfunction
-Cardiac pacemakers or defibrillators
a- Including isolated ventricular defects, transposition of the great vessels and tetralogy of Fallot; b- Including ventricular
septal defect, bicuspid aortic valve, primum atrial septal defects, patent ductus arteriosus and coarctation of the aorta;
c- Including atrial and ventricular septal defects and patent ductus arteriosus; d- If the precise nature of the murmur is
not known, specialist opinion should be sought.
Table 1. Classification of patients at risk of IE: AHA guideline (1997) [47].
The AHA also defined the profile of the patient with mitral valve prolapse in whom prophy‐
laxis should be given as male, over 45 years of age, with mitral valve thickening and/or
regurgitation. If the patient required emergency dental treatment and it was not known
whether or not regurgitation secondary to the prolapse was present, the AHA recommended
antibiotic prophylaxis. The AHA also stated that, whilst auscultation enabled innocent cardiac
murmurs to be defined clearly in paediatric patients, their diagnosis in adults required
complementary studies, such as echocardiography. Finally, the AHA reiterated that many
professionals classified heart transplant recipients as having a moderate risk of IE indefinitely,
as they were patients with a particular tendency to develop valve dysfunction (particularly
during episodes of rejection) and because they were usually on immunosuppressants; these
patients should therefore receive antibiotic prophylaxis [47].
In the guideline proposed by the ESC in 2004 [55], the classification of at-risk patients was
similar to that published previously by the AHA in 1997 [47]. For the ESC, the classification
represented a class I recommendation (when there is evidence and/or general agreement that
a certain treatment or diagnostic approach is beneficial, useful or effective) with level C
evidence (when there is expert consensus based on clinical trials or investigations). For the first
time, the ESC added a number of so-called non-cardiac conditions in which antibiotic pro‐
phylaxis should be given: conditions that favour the development of nonbacterial thrombotic
vegetations, those which compromise immune function and/or local non-immune defence
mechanisms in the host and advanced age [55].
In 2004, the BSC and RCP indicated that the risk of developing IE varied according to the
underlying cardiac abnormality and that, in the case of congenital heart disease, it depend‐
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ed on the haemodynamic repercussions of the condition and whether surgical treatment was
palliative or curative [56].  To reflect  these differences in susceptibility to IE,  the experts
established 3 risk groups (Table 2). The principal differences to be found on comparison with
the classifications of at-risk patients published previously by the AHA [47] and ESC [55]
were that  mitral  valve prolapse with regurgitation and/or thickening of  the leaflets  was
incorporated into the high-risk group and that  prophylaxis  was recommended up to 12
months after  atrial  septal  defect/patent  foramen ovale  (ASD/PFO) catheter-based closure
procedures and only for the first 6 months after heart and/or lung transplant [56]. The BSC
and RCP also recommended that all patients at risk of IE should have a card with the following
information:  type of cardiac lesion,  degree of  risk of developing IE,  history of  penicillin
allergy,  the prophylactic regimen that should be administered, and name and telephone
number of the cardiologist [56].
PROPHYLAXIS RECOMMENDED PROPHYLAXIS NOT RECOMMENDED
HIGH RISK OF IE
-Prosthetic heart valves
-Previous episodes of IE
-Cyanotic congenital heart disease
-Transposition of the great vessels
-Tetralogy of Fallot
-Gerbode’s defect
-Surgically constructed systemic-pulmonary shunts or
conduits
-Mitral valve prolapse with clinical repercussiona
MODERATE RISK OF IE
-Acquired valve disease (e.g. due to rheumatic heart
disease)
-Aortic stenosis
-Aortic regurgitation
-Mitral regurgitation
-Structural heart defectsb
-Hypertrophic obstructive cardiomyopathy
-Subaortic membrane
LOW RISK OF IE
-Pulmonary stenosis
-Surgically repaired structural heart defectsc
-Post Fontan or Mustard procedure with no residual
murmur or defect
-Isolated secundum atrial septal defectd
-Previous coronary artery bypass surgery
-Mitral valve prolapse without regurgitation
-Innocent heart murmurse
-Cardiac pacemakers or defibrillatorsf
-Coronary artery stent implantation
-Heart and/or lung transplantg
a- Presence of mitral valve regurgitation and/or thickening of the valves; b- Including ventricular septal defects, bicuspid aortic
valve, primum atrial septal defects, patent ductus arteriosus, aortic root replacement, coarctation of the aorta, atrial septal
aneurysm and patent foramen ovale; c- Including atrial septal defect, ventricular septal defect and patent ductus arteriosus; d-
Antibiotic prophylaxis recommended up to 12 months after catheter closure of ASD/PFO; e- If the precise nature of the murmur
is not known, the opinion of a cardiologist should be sought; in emergency situations, even if the possible repercussion of the
murmur is not known, prophylaxis may be administered for certain dental procedures; f- With the exception of patients consid‐
ered to have a moderate or high risk of IE, in whom antibiotic prophylaxis is recommended; g- Antibiotic prophylaxis is recom‐
mended for the first 6 months after surgery.
Table 2. Classification of patients at risk of IE: BCS and RCP (London) guideline (2004) [56].
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In recent years, the updated guidelines published by the BSAC [53], the AHA [48], the NICE
[57] and the ESC [58] have limited prophylaxis to high-risk patients, but the cardiac conditions
included by each Expert Committee differ (Table 3). For example, according to the latest
AHA guideline,  IE prophylaxis  for  dental  procedures  should be recommended only for
patients  with  underlying  cardiac  conditions  associated  with  the  highest  risk  of  adverse
outcome from IE. The conditions included in the list were prosthetic heart valves, previous
IE, congenital heart disease (unrepaired defect, repaired defect with residual alterations and
the first 6 months after complete repair of a defect) and heart transplant recipients who
develop valve disease [48]. Although the AHA guideline recommended prophylaxis in heart
transplant recipients who developed valve disease, the ESC stated that such a recommenda‐
tion was not supported by strong evidence. In addition, although the risk of an adverse
outcome was high when IE occurred in transplant patients, the probability of IE of oral origin
was extremely low in these patients. Consequently, the ESC did not recommend prophylax‐
is in such situations [58]. The ESC recommended prophylaxis for cardiac conditions associated
with the highest risk of IE (the list is similar to the one proposed by the AHA, except for
heart transplant) based on a Class IIa recommendation (weight of evidence/opinion is in
favour of usefulness/efficacy) and Level C evidence (consensus of opinion of the experts and/
or small studies, retrospective studies, registries)[58]. The NICE also included other cardiac
conditions at risk of IE, such as acquired valve disease with stenosis or regurgitation and
hypertrophic cardiomyopathy [57].
In our opinion, this lack of consensus could provoke conflicting situations for clinicians at the
time of identifying high-risk patients requiring antibiotic prophylaxis, and this could have
medico-legal repercussions. However, if a clinician takes into account all the high-risk cardiac
conditions defined each of the Expert Committees, there would be no omissions from the group
of at-risk patients requiring antibiotic prophylaxis compared with previous IE prophylaxis
protocols [59].
3.2. At-risk dental procedures
In 1960, the AHA stated that the dental procedures in which prophylaxis was indicated were
dental extractions and gingival treatments, specifying that these procedures frequently caused
transient bacteraemia and that the bacteraemia was more intense in patients with oral
infections. They also admitted that certain normal activities such as toothbrushing and
chewing gave rise to bacteraemia, although of lower intensity [41].
In 1972, a dentist, Dean Millard, was incorporated for the first time onto the AHA panel of
experts; this led to recognition of the importance of a good oral health status in minimising
the risk of developing IE of oral aetiology. The administration of antibiotic prophylaxis was
recommended before performing any dental procedure associated with the potential for
causing bacteraemia, the intensity of which depended on the magnitude of the procedure, the
degree of the trauma to the gingival tissues and the presence of infection. Prophylaxis was
therefore recommended for any dental procedure that caused gingival bleeding [43]. Five years
later, the AHA recognised the impossibility of predicting which dental procedures could be
responsible for causing IE. Antibiotic prophylaxis was recommended for treatments that can
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cause gingival bleeding, such as scaling, but not for procedures such as the adjustment of
orthodontic appliances and the exfoliation of primary teeth [44].
In the first guideline for the prevention of IE published by the BSAC in 1982, antibiotic
prophylaxis was recommended exclusively for dental extractions, scaling and root planing
and periodontal surgery [49]. In 1986, the AHA confirmed that certain dental procedures such
as dental extractions were associated with a higher frequency of significant bacteraemia than
other treatments [50]. In 1990, the AHA reported that bacteraemia secondary to dental
procedures did not persist for more than 15 minutes after completion of the procedure.
However, their Committee reiterated the importance of maintaining an optimal oral health
status in patients considered to be at risk of IE. On this matter, dentists were encouraged to
minimise gingival inflammation. Curiously, the AHA also discussed the need to control the
fit of dental prostheses in edentulous patients as there was a possibility of developing
PROPHYLAXIS RECOMMENDED
BSAC, 2006 AHA, 2007/ESC, 2009
-Previous episodes of IE
-Prosthetic heart valve
-Surgically constructed systemic or pulmonary shunt
or conduit
-Previous episodes of IE
-Prosthetic heart valve
-Congenital heart disease (CHD)a
Unrepaired cyanotic CHD, including palliative shunts and
conduits
First 6 months after complete repair of a congenital heart
defect with prosthetic material or device, whether placed
by surgery or by catheter interventionb
Repaired congenital heart defect with residual defects at
the site or adjacent to the site of a prosthetic patch or
prosthetic device (which inhibits endothelialisation)
-Heart transplant recipients who develop valve diseasec
NICE, 2008
-Previous episodes of IE
-Prosthetic heart valve
-Acquired valve disease with stenosis or regurgitation
-Structural congenital heart disease, including surgically corrected or palliated structural conditions, but excluding
isolated atrial septal defect, fully repaired ventricular septal defect or fully repaired patent ductus arteriosus, and
closure devices that are judged to be endothelialised
-Hypertrophic cardiomyopathy
a- Except for the conditions listed above, antibiotic prophylaxis is no longer recommended for any other form of CHD;
b- Prophylaxis is recommended because endothelialisation of prosthetic material can take up to 6 months after the
procedure; c- Although the AHA guideline recommend prophylaxis in heart transplant recipients who develop valve
disease, the ESC Task Force does not recommend prophylaxis in such situations.
Table 3. High-risk cardiac conditions requiring antibiotic prophylaxis for IE: guidelines of the BSAC (2006), the AHA
(2007), the NICE of the United Kingdom (2008) and the ESC (2009) [48,53,57,58].
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bacteraemia because of mucosal ulceration due to poorly fitting prostheses [46]. For its part,
the BSAC, in 1992, pronounced for the first time against the use of intraligamental local
anaesthesia in patients considered to be at risk of IE [52].
In 1995, the ESC declared that dental treatment constituted the principle risk factor for IE and
that all procedures should therefore be performed under antibiotic prophylaxis, with the
exception of superficial fillings and supragingival prosthetic preparations. However, the ESC
recognised that although at-risk dental procedures led to a high prevalence of bacteraemia,
this was not predictive of the risk of developing IE. In this context, the duration of the
procedure could represent a possible conditioning factor [54].
In its guideline published in 1997, the AHA listed the dental procedures that required antibiotic
prophylaxis and those in which this was not necessary (Table 4) [47].
PROPHYLAXIS RECOMMENDED PROPHYLAXIS NOT RECOMMENDED
-Dental extractions
-Periodontal proceduresa
-Placement of implants and reimplantation of avulsed
teeth
-Endodontal instrumentation or periapical surgery
-Placement of subgingival antibiotic fibres or strips
-Initial placement of orthodontic bands
-Intraligamental anaesthetic injections
-Cleaning of teeth or implantsb
-Restorative dentistry (operative and prosthodontic) with or
without retraction cord
-Non-intraligamental anaesthetic injections
-Intracanal post placement and build-up
-Placement of a rubber dam
-Removal of sutures
-Placement of removable prosthetic or orthodontic appliances
-Intra-oral impressions
-Fluoride treatments
-Intra-oral radiographs
-Orthodontic appliance adjustment
-Exfoliation of primary teeth
a- Including surgery, root planing and scaling, probing and maintenance; b- When bleeding is anticipated.
Table 4. Dental procedures and antibiotic prophylaxis in patients with a high or moderate risk of IE: AHA guideline
(1997) [47].
In general,  as in previous protocols,  antibiotic prophylaxis was recommended for dental
procedures associated with gingival bleeding but it was not recommended for restorative
dental procedures (with or without gingival retraction), the placement of a rubber dam or
the removal of sutures. Although the possibility of developing bacteraemia secondary to
traumatic ulcers caused by poorly fitting prostheses had previously been included, the AHA
no longer recommended prophylaxis in edentulous patients during the fitting of complete
prostheses [47].
In 2004, in agreement with previous guidelines [47,52,54], the ESC once again recommended
antibiotic prophylaxis for “dental treatments that caused gingival or mucosal trauma” [55]. In
contrast, the BCS and the RCP modified certain aspects concerning bacteraemia of oral origin
[56]. First, they excluded the concept of "procedures that cause bleeding" as a criterion for the
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indication for antibiotic prophylaxis in patients at risk of IE; they also re-evaluated the
definition of "significant bacteraemia" which, according to their new interpretation, was defined
as "bacteraemia secondary to a dental procedure that was statistically significant with respect to the
bacteraemia present under basal conditions (prior to any manipulation)". Considering these new
provisions, the indication for prophylaxis included not only surgical procedures such as dental
extractions or mucoperiosteal flaps but also other less traumatic procedures such as the
placement of a rubber dam, matrices, wedges or retraction cords (Table 5) [56]. Although that
Committee recognised the existence of bacteraemia secondary to activities considered to be
physiological (such as toothbrushing), it also recognised the impossibility of administering
prophylaxis for such practices due to the high risk of potentiating the development of bacterial
resistance [56].
In 2006, the BSAC summarized the indications for antibiotic prophylaxis for high-risk patients
stating that it should be given for “all dental procedures involving dento-gingival manipulation or
endodontics” [53]. According to the latest AHA and ESC guidelines, prophylaxis was recom‐
mended for all dental procedures that involved manipulation of gingival tissues or the
periapical region of teeth or perforation of the oral mucosa. This included procedures such as
biopsies, suture removal and placement of orthodontics bands, but it did not include routine
anaesthetic injections through non-infected tissue, taking dental radiographs, placement of
removable prosthodontic or orthodontic appliances, placement of orthodontic brackets, or
adjustment of orthodontic appliances [48,58]. The dental procedures with the highest risk of
IE and for which prophylaxis was recommended were associated with a Class IIa recommen‐
dation (weight of evidence/opinion is in favour of usefulness/efficacy) and Level C evidence
(consensus of opinion of the experts and/or small studies, retrospective studies, registries) [58].
There are other events for which prophylaxis was not recommended, such as shedding of
deciduous teeth and trauma to the lips or oral mucosa [48].
In the latest guidelines published by the BSAC, the AHA, the NICE of the United Kingdom,
and the ESC, the emphasis for the cause of IE shifted from procedure-related bacteraemia to
cumulative bacteraemia due to everyday oral activities [48,53,57,58]. The NICE considered that
it was biologically implausible that a dental procedure would lead to a greater risk of IE than
regular toothbrushing. On the other hand, even some expert committee guidelines concurred
with the premise “Maintenance of optimal oral hygiene and periodontal health may reduce the
incidence of bacteraemia of oral origin and, in the context of a dental procedure, is more important than
prophylactic antibiotics to reduce the risk of IE” [48,58].
The NICE has adopted a drastic stance in this respect, issuing the statement that “antibiotic
prophylaxis for IE is not recommended in individuals undergoing dental procedures” [58]. Recently,
following the introduction in March 2008 of a clinical guideline from NICE recommending the
cessation of antibiotic prophylaxis in the United Kingdom, Thornhill et al [60] quantified the
change in the prescription of antibiotic prophylaxis to patients at risk of IE undergoing invasive
dental procedures and looked for any concurrent change in the incidence of IE. Despite a 78.6%
reduction in the prescription of antibiotic prophylaxis after the introduction of the NICE
guideline, that study detected no large increase in the incidence of cases of IE or of IE-related
deaths over the following 2 years. Those authors concluded that ongoing data monitoring was
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TYPE OF PROCEDURE PROPHYLAXIS RECOMMENDED PROPHYLAXIS NOT RECOMMENDED
ORAL SURGERY -Extraction of a single tooth
-Extraction of multiple teeth
-Mucoperiosteal flap for access to a tooth or
lesion
-Dental implants (as for mucoperiosteal flap)
-Incision and drainage of an abscess
-Biopsy
-Insertion of implants (transmucosal approach)
-Exfoliation of primary teeth
-Suture removal
-Removal of surgical packs
PERIODONTICS -Periodontal surgery
-Gingivectomy
-Root curettagea
-Root planing (similar to curettage)
-Placement of antibiotics in the gingival
sulcusb
-Rubber cup polishing
-Oral irrigation with water
-Air polishing
ENDODONTICS -Root canal instrumentation beyond the apex
-Reimplantation of avulsed teethc
-Root canal instrumentation (within the root
canal)
-Pulpotomy of primary molars
-Pulpotomy of permanent molarsd
ORTHODONTICS -Placement of interproximal separators
-Exposure of unerupted teeth
-Band placement and cementation
-Band removal
-Adjustment of fixed appliances
-Taking alginate impressions
CONSERVATIVE
DENTISTRY
-Placement of a rubber dam
-Matrix band and wood wedge placement
-Placement of a retraction cord
-Slow and fast drilling (without a rubber dam)
PREVENTIVE DENTISTRY -Fossa and fissure sealing
-Fluoride application
ANAESTHETIC
TECHNIQUES
-Local intraligamental -Local infiltrative
-Local nerve block
-General with oral intubation
-General with nasal intubation
-General with laryngeal mask
EXPLORATION
TECHNIQUES
-Periodontal probing -Dental examination with mirror and probe
DIAGNOSTIC
TECHNIQUES
-Sialography -Intra-oral radiographs
-Extra-oral radiographs
a- Both supra and subgingival, with manual instrumentation or ultrasound; b- Although there are no studies on this
subject, this procedure is very similar to the placement of a retraction cord; c- Antibiotic prophylaxis may be administered
up to 2 hours after dental reimplantation; d- Although there are no studies on this subject, this procedure is very similar
to pulpotomy of primary molars.
Table 5. Dental procedures and antibiotic prophylaxis in patients with a high or moderate risk of IE: BCS and RCP
(London) guideline (2004) [56].
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needed to confirm this observation supporting the NICE guideline and that further clinical
trials should be performed to determine if antibiotic prophylaxis still has a role in protecting
some patients at particularly high risk [60].
3.3. Anaesthetic technique
In 1960, the AHA recommended the administration of antibiotic prophylaxis for any surgical
intervention (including those in the orofacial area) performed under general anaesthesia in
patients considered to be at risk of IE [41]. However, in subsequent protocols published by the
AHA, no specific observations were made with regard to the type of anaesthesia used [42-48].
The BSAC, on the other hand, specified for the first time in 1982 that when dental treatment
was performed under general anaesthesia, special prophylactic protocols should be applied,
also considering that "If patients due to undergo a general anaesthesia have prosthetic heart valves
and/or are allergic to penicillin and/or have received prolonged treatment with penicillin and/or have
had previous episodes of IE, their dental problems should be treated in a hospital environment"
[49]. The BSAC has maintained that opinion in its protocols on IE prevention published in
1986, 1990 and 1992 [50-52]. In 1995, the ESC also included the anaesthetic technique among
the factors to be taken into account when choosing the prophylactic regimen [54]. In the
guideline published by the BCS and RCP in 2004, specific prophylaxis regimens were included
for dental procedures performed under general anaesthesia [56].
In agreement with the AHA, the latest protocols of the BSAC and ESC on IE prevention
recommend antibiotic prophylaxis irrespective of whether the dental procedure is performed
under general or local anaesthesia [53,58].
3.4. Antibiotics of choice, dose and route of administration
In 1960, the AHA pronounced in favour of administering antibiotic prophylaxis from between
24 and 48 hours before the dental procedure, even in the absence of intraoral infections, in
order to reduce the intensity of the post-manipulation bacteraemia [41]. However, in view of
the problem of bacterial resistance, it was also suggested that prophylaxis could be adminis‐
tered immediately before the procedure. According to the AHA, the choice of one or other
regimen depended on the professional, who should evaluate the probability of infection in
order to decide when the prescription of antibiotics was indicated. In contrast to the guideline
published in 1955 [39], the exclusively oral protocols were excluded in favour of intramuscular
administration, although penicillin continued to be the antibiotic of choice; the prophylactic
regimen consisted of several injections of penicillin from 2 days before up to 2 days after the
session of dental treatment. A combined intramuscular-oral prophylactic regimen was also
elaborated. For patients with a history of penicillin allergy, the AHA was the first to recom‐
mended erythromycin at doses of 250 mg orally 4 times a day (for adults and older children);
in small children, the dose of erythromycin was of 20 mg/kg body-weight per day, divided
into 3 or 4 doses, not exceeding a total dose of 1 g per day [41].
In 1965, the AHA stated that antibiotic prophylaxis should only be administered immediately
before the dental procedure and on the subsequent days; this recommendation was based on
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the argument that penicillin did not sterilise the apical foci, and that its excessive use led to
the selection of a resistant oral flora. The AHA also reduced the parenteral regimen to a single
injection of several penicillins. In those cases in which the complete collaboration of the patient
could be anticipated, an exclusively oral regimen of several doses of penicillin was proposed.
Erythromycin was recommended for patients allergic to penicillin [42].
In 1972, the AHA modified its recommendations to include an increase in the initial doses
of penicillin and erythromycin administered orally and the use of erythromycin in patients
on prolonged treatments with penicillin, as penicillin-resistant Streptococcus viridans could
predominate in their oral flora [43]. Five years later, the AHA suggested increasing the initial
dose of  the antibiotic  even further in order to reach higher serum concentrations at  the
moment  at  which  the  microorganism entered the  bloodstream [44].  However,  they  fav‐
oured the parenteral regimen, particularly in patients considered to be at high risk of IE. Two
regimens were recommended: regimen A, based on the use of penicillin (erythromycin was
recommended  in  patients  allergic  to  penicillin)  for  parenteral-oral  or  exclusively  oral
administration, and regimen B, which combined penicillin and streptomycin (vancomycin
and erythromycin for patients allergic to penicillin) for parenteral-oral administration. This
latter protocol was reserved for patients with prosthetic heart valves, although patients with
a  good  oral  health  status  could  receive  the  oral  prophylaxis  regimen  for  certain  non-
surgical dental procedures [44].
The BSAC, in its first guideline, suggested a single prophylactic regimen of a single dose of
amoxicillin before the dental procedure for all patients considered to be at risk of IE (including
patients with prosthetic heart valves) [49]. The BSAC substituted penicillin V, previously
recommended by the AHA [44], with amoxicillin due to its more favourable pharmacokinetic
and pharmacodynamic characteristics. Erythromycin stearate was the antibiotic of choice in
patients allergic to penicillin but because this macrolide has lower activity than amoxicillin
against some oral streptococci and showed a lower absorption after a single oral dose, they
proposed a second dose 6 hours after completing the dental procedure. One quarter of the
adult dose was recommended in children under 5 years of age and a half dose in those of 5 to
10 years of age [49]. In contrast to the AHA [44], the BSAC proposed a combined intramuscular-
oral regimen in patients undergoing dental treatment under general anaesthesia. Special
prophylactic regimens were proposed for patients being treated in the hospital environment;
these regimens were based on the association of amoxicillin and gentamycin or, in patients
unable to receive penicillin, a combination of vancomycin and gentamycin; the following doses
were used in children under 10 years of age: amoxicillin, half the adult dose; gentamycin, 2
mg/kg body-weight; and vancomycin, 20 mg/kg body-weight [49].
In its protocol published in 1984, the AHA reduced the dose of the antibiotic after completion
of the dental treatment, recommending the administration of penicillin V before the dental
procedure and a second dose 6 hours after the first. In those patients in whom the oral route
was not available, intramuscular penicillin G was proposed before the procedure and 6 hours
later [45]. The AHA also showed a clear preference for the parenteral route in patients at high
risk of IE and drew up a special regimen for these patients consisting of intramuscular or
intravenous ampicillin and gentamycin, together with a second dose of penicillin V orally;
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intravenous vancomycin was recommended for patients allergic to penicillin, eliminating the
second dose of erythromycin [45].
In 1986, the BSAC suggested that vancomycin should be given by slow intravenous infusion
over 60 minutes (instead of the previously recommended 30 minutes) to minimise adverse
reactions such as episodes of hypotension caused by histamine release (red-man syndrome)
[50]. As an alternative to the parenteral regimen proposed earlier, the BSAC proposed 2 oral
regimens for patients without prosthetic heart valves undergoing dental treatment under
general anaesthesia. The first was based on the administration of amoxicillin before anaesthetic
induction followed by a second dose in the immediate postoperative period; the second
regimen consisted of the combination of amoxicillin and probenecid administered before
anaesthesia [50]. For the first time, the BSAC differentiated between patients with prosthetic
heart valves and other patients considered to be at risk of IE, as the AHA [45] had done in its
1984 guideline, proposing specific oral prophylactic regimens for such patients undergoing
dental treatment under local anaesthesia [50].
Differing from the BSAC guideline [50], the 1990 AHA guideline continued to favour regi‐
mens based on 2 doses. Of particular note amongst the novelties introduced in this protocol was
the incorporation of amoxicillin as the antibiotic of choice for all groups at risk of IE [46], an
approach that had been adopted by the BSAC in 1982 [49]. According to the AHA, amoxicillin,
ampicillin and penicillin showed similar efficacy against α-haemolytic streptococci in vitro but
amoxicillin reached higher serum concentrations due to its better gastrointestinal absorption.
However, they also defended the use of penicillin V as a suitable alternative for prophylaxis in
dental procedures. Erythromycin, in its ethylsuccinate or stearate salt preparations, continued
to be the antibiotic of choice in patients allergic to penicillin, being administered 2 hours before
the procedure to ensure high serum concentrations. For the first time, the AHA recommended
the administration of clindamycin in patients intolerant to penicillin and erythromycin [46]. For
patients unable to take oral medication, the AHA drew up a number of regimens for parenter‐
al administration as alternatives to the standard protocol, proposing ampicillin (in patients not
allergic to penicillin) and clindamycin (in penicillin-allergic patients) as the antibiotics of choice
[46]. In contrast to the previous protocols [45], the AHA recommended the administration of the
standard regimen to patients with prosthetic heart valves and other patients considered to be at
high risk of IE (patients with a past history of IE and those with surgically constructed systemic-
pulmonary  shunts).  However,  recognising  that  some  professionals  preferred  parenteral
prophylaxis, they also drew up a special parenteral regimen for this type of patient [46].
The prophylactic protocol recommended by the BSAC in 1990 included a new option [51]. Due
to the high prevalence of undesirable gastrointestinal effects caused by erythromycin, and
based on the guideline published in 1984 by the Swiss Expert Committee for the prevention
of IE [61], the BSAC proposed the administration of a single oral dose of 600 mg of clindamycin
1 hour before the procedure as an alternative in patients with penicillin allergy; the dose of
clindamycin in children under 10 years of age was of 6 mg/kg body-weight [51]. In 1992, the
BSAC definitively replaced erythromycin with clindamycin in patients allergic to penicillin,
modifying the initial dose in children to 300 mg in those between 5 and 10 years of age and to
150 mg in those under 5 years [52]. Due to the high prevalence of adverse effects associated
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with vancomycin and its prolonged duration of administration (around 100 minutes), the
BSAC drew up 2 alternative regimens for penicillin-allergic patients with a high risk of IE who
were being treated in the hospital environment. One was based on the intravenous combina‐
tion of teicoplanin and gentamycin (in children under 14 years of age the doses were teico‐
planin, 6 mg /kg body-weight, and gentamycin, 2 mg/kg body-weight); and the other consisted
of an intravenous infusion of clindamycin with a second dose 6 hours after the first. Finally,
in patients undergoing dental treatment under general anaesthesia, the BSAC specified that
prophylaxis with amoxicillin should be administered intravenously instead of intramuscular‐
ly, particularly in children [52].
In 1995, the ESC performed a critical review of the prophylaxis protocols drawn up by the
different national committees, noting clear differences between countries, although all
included a simple or standard regimen and another more complex regimen for use in special
circumstances [54]. In general, the standard guidelines consisted of the oral administration of
a single dose of antibiotic which, in the majority of countries, was amoxicillin. Some societies
recommended the administration of a second dose, particularly in patients considered to be
at high risk of IE. In patients allergic to the beta-lactams, the antibiotic of choice was clinda‐
mycin at doses between 300 mg and 600 mg, although some countries, for example, Holland
and France, recommended other antibiotics such as erythromycin or pristinamycin [54]. The
more complex regimens were based on the synergistic and prolonged effect provided by
several doses of different antibiotics with the aim of increasing the safety margin in special
situations. In an analysis performed by the ESC, it was found that the majority of protocols
recommended ampicillin or amoxicillin by intravenous infusion followed by a second oral
dose 6 hours later; there were only minor differences with respect to the doses used. Although
some countries did not use the aminoglycosides, these were recommended in other countries
in patients considered to be at high risk of IE. The most frequently used antibiotic of choice in
patients allergic to penicillin was vancomycin by intravenous infusion; for some scientific
societies, teicoplanin and clindamycin were possible antimicrobial alternatives [54]. According
to the ESC, the choice of the most suitable prophylactic regimen should be based on the
following considerations: the heart condition defined as carrying a risk of IE; the type,
magnitude and duration of the dental procedure; and the type of anaesthesia used (local or
general). The ESC therefore considered the possibility of individualising the antibiotic
prophylaxis regimen in certain situations [54]. The oral regimen proposed by the ESC consisted
of the administration of amoxicillin or clindamycin (in penicillin-allergic patients), whilst the
combination of amoxicillin or ampicillin with gentamycin and a second dose of amoxicillin
orally 6 hours later was recommended in the parenteral regimen. In patients allergic to
penicillin, the association of vancomycin and gentamycin was recommended, administering
a second dose of vancomycin by intravenous infusion 12 hours after the first dose [54].
The prophylactic protocol recommended by the AHA in 1997 is shown in Table 6 [47]. It is based
on a single dose of amoxicillin administered orally 1 hour before the procedure. In this proto‐
col, the dose of amoxicillin was reduced from 3 g to 2 g after confirming that this latter dose
provided adequate serum levels of the drug over several hours and caused fewer adverse
gastrointestinal effects. Accepting an approach that had been adopted by other societies several
years earlier [49-52], the AHA recognised that the administration of a second dose of antibiotic
was unnecessary, since the serum levels of the drug exceeded the minimum inhibitory concentra‐
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tions of many oral Streptococcus spp. and the antimicrobial activity of amoxicillin was pro‐
longed (6 to 14 hours). In patients allergic to penicillin, the antibiotics of choice were clindamycin,
cephalosporins  (cefalexin  or  cefadroxil)  or  macrolides  (azithromycin  or  clarithromycin),
although the AHA specified that the cephalosporins should be avoided in patients with type 1
hypersensitivity to penicillin [47]. In patients unable to take oral medication or with problems of
gastrointestinal absorption (independently of the IE risk category), the AHA drew up a regi‐
men based on the use of intramuscular or intravenous ampicillin 30 minutes before the proce‐
dure. In penicillin-allergic patients in whom parenteral administration of the antibiotic was
required, the recommended antibiotic was clindamycin phosphate and, in those patients not
presenting type 1 hypersensitivity, was cefazolin. Although erythromycin was abandoned
because of its gastrointestinal complications and its particular pharmacokinetic characteristics,
the AHA indicated that “Dentists who are used to prescribing this antibiotic successfully for prophylax‐
is may continue to use it” [47].
STANDARD REGIMEN (ORAL)
NOT ALLERGIC TO PENICILLIN
ADULTS
2 g of amoxicillin 1 h before tmt
CHILDREN
50 mg/kg body-weight of amoxicillin 1 h before tmt
ALLERGIC TO PENICILLIN
ADULTS
A) 600 mg of clindamycin 1 h before tmt
B) 2 g of cefalexin or cefadroxil 1 h before tmta
C) 500 mg of azithromycin or clarithromycin 1 h before tmt
CHILDREN
A) 20 mg/kg body-weight of clindamycin 1 h before tmt
B) 50 mg/kg body-weight of cefalexin or cefadroxil 1 h before
tmta
C) 15 mg/kg body-weight of azithromycin or clarithromycin 1
h before tmt
PARENTERAL REGIMENb
NOT ALLERGIC TO PENICILLIN
ADULTS
2 g of ampicillin (IM or IV) 30 min before tmt
CHILDREN
50 mg/kg body-weight of ampicillin (IM or IV) 30 min before
tmt
ALLERGIC TO PENICILLIN
ADULTS
A) 600 mg of clindamycin (IV) 30 min before tmt
B) 1 g of cefazolin (IM or IV) 30 min before tmt
CHILDREN
A) 20 mg/kg body-weight of clindamycin (IV) 30 min before
tmt
B) 25 mg/kg body-weight of cefazolin (IM or IV) 30 min
before tmt
tmt= treatment; min= minutes; h= hours; IM= intramuscular; IV=intravenous; mg= milligrams; g= grams; kg= kilograms.
a- The cephalosporins must not be administered to subjects with immediate hypersensitivity reactions to penicillin
(urticaria, angioedema or anaphylaxis); b- This protocol is to be applied in patients unable to take the medication orally;
the total dose in children should not exceed the adult dose.
Table 6. IE prophylaxis protocol for dental procedures: recommendation of the AHA (1997) [47].
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In 2004, the ESC published a guideline on IE prophylaxis which were very similar to the 1997
guideline of the AHA [47], except that the use of cephalosporins in patients allergic to penicillin
was excluded [55].
In the prophylaxis protocol for IE secondary to dental procedures drawn up by the BSC and
RCP (London) in 2004, prophylaxis was reserved for patients with heart diseases included in
the categories of high and moderate risk of IE, and the prophylactic regimens varied according
to the type of anaesthesia used [56]. Oral prophylaxis regimens were to be administered in
procedures performed under local anaesthesia and parenteral regimens for those performed
under general anaesthesia (Tables 7 and 8) [56]. In contrast to the 1997 guideline of the AHA
[47], the BCS and RCP also provided a special prophylactic regimen for patients with prosthetic
heart valves and/or previous episodes of IE (Table 9) [56].
The most recent IE prophylaxis protocols published by the BSAC [53], the AHA [48] and
the ESC [58] are very similar and are summarized in Tables 10 and 11. The most recent
prophylactic protocol published by the AHA continues to recommend amoxicillin as the
antibiotic of choice for oral prophylaxis. For individuals who are allergic to penicillins, the
use of cephalexin or another first-generation oral cephalosporin, clindamycin, azithromy‐
cin or clarithromycin is recommended [48]. Because of possible cross-reactions, a cephalo‐
sporin must not be administered to patients with a history of anaphylaxis, angioedema or
urticaria after  treatment with any form of  penicillin,  including ampicillin or amoxicillin.
Patients who are unable to tolerate an oral antibiotic may be treated with intramuscular
or intravenous ampicillin, ceftriaxone or cefazolin. For penicillin-allergic patients who are
unable to tolerate  an oral  agent,  prophylaxis  is  recommended with parenteral  cefazolin,
ceftriaxone or clindamycin [48]. According to the ESC, the main aim of antibiotic prophy‐
laxis  in patients  at  risk of  IE is  to target  the oral  streptococci.  The impact  of  increasing
resistance of these pathogens on the efficacy of antibiotic prophylaxis is unclear. Fluoroqui‐
nolones  and  glycopeptides  are  not  recommended  because  their  efficacy  has  not  been
established and because of the potential induction of resistance [58].
It has been estimated that the number of cases of IE that result from dental interventions is
very small. The AHA has therefore concluded that only an extremely small number of cases
of IE will be prevented by antibiotic prophylaxis for dental procedures even if such prophy‐
lactic regimens are 100% effective [48]. According to the ESC, this observation leads to 2
conclusions: (i) IE prophylaxis can at best only protect a small proportion of patients; and (ii)
the bacteraemia that causes IE in the majority of patients appears to derive from another source
[58]. Finally, the AHA stated the need for prospective placebo-controlled studies of antibiotic
prophylaxis for IE to evaluate its efficacy in IE prevention [48].
Reviewing the effect  of  antibiotic prophylaxis on the intensity and duration of bacterae‐
mia following dental procedures, the NICE recently concluded that “Antibiotic prophylaxis
does not eliminate bacteraemia following dental procedures but some studies show that it does reduce
the frequency of detection of post-procedure bacteraemia” [57]. This conclusion was reached after
analysis of a number of studies on the efficacy of antibiotic prophylaxis for the preven‐
tion  of  post-dental  manipulation  bacteraemia;  those  studies  presented  methodological
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differences with respect to the type of antibiotic used and the time and route of adminis‐
tration. These important differences make a comparison of the results between the different
series inappropriate [59].
STANDARD REGIMEN (ORAL)
NOT ALLERGIC TO PENICILLIN
ADULTS
3 g of amoxicillin 1 h before tmt
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN BETWEEN 5 AND 10 YEARS OF AGE
1.5 g of amoxicillin 1 h before tmt
CHILDREN UNDER 5 YEARS OF AGE
750 mg of amoxicillin 1 h before tmt
ALLERGIC TO PENICILLINa
ADULTS
600 mg of clindamycin 1 h before tmt
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN BETWEEN 5 AND 10 YEARS OF AGE
300 mg of clindamycin 1 h before tmt
CHILDREN UNDER 5 YEARS OF AGE
150 mg of clindamycin 1 h before tmt
UNABLE TO TAKE ORAL MEDICATIONb
ADULTS
500 mg of azithromycin 1 h before tmt
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN BETWEEN 5 AND 10 YEARS OF AGE
300 mg of azithromycin 1 h before tmt
CHILDREN UNDER 5 YEARS OF AGE
200 mg of azithromycin 1 h before tmt
h= hours; tmt= treatment; mg= milligrams; g= grams.
a- This protocol should also be used in patients who have received penicillin or another beta-lactam on more than 1
occasion in the previous month; b- In Great Britain, clindamycin is not available in oral suspension.
Table 7. IE prophylaxis protocol for dental procedures performed under local anaesthesia: recommendation of the
BCS and RCP (London) (2004) [56].
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PARENTERAL REGIMEN
NOT ALLERGIC TO PENICILLIN
ADULTS
2 g of amoxicillin or ampicillin (IV) during anaesthetic induction
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN BETWEEN 5 AND 10 YEARS OF AGE
500 mg of amoxicillin or ampicillin (IV) during anaesthetic induction
CHILDREN UNDER 5 YEARS OF AGE
250 mg of amoxicillin or ampicillin (IV) during anaesthetic induction
ALLERGIC TO PENICILLINa
ADULTS
300 mg of clindamycin (IV over 10 min) during anaesthetic
induction
150 mg of clindamycin (oral or IV) 6 h after the first dose
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN BETWEEN 5 AND 10 YEARS OF AGE
150 mg of clindamycin (IV over 10 min) during anaesthetic induction
CHILDREN UNDER 5 YEARS OF AGE
75 mg of clindamycin (IV over 10 min) during anaesthetic induction
min= minutes; h= hours; IV= intravenous; mg= milligrams; g= grams; kg= kilograms.
a-This protocol should also be used in patients who have received penicillin or another beta-lactam on more than 1
occasion in the previous month.
Table 8. IE prophylaxis protocol for dental procedures under general anaesthesia: recommendation of the BCS and
RCP (London) (2004) [56].
PARENTERAL REGIMEN
NOT ALLERGIC TO PENICILLIN
ADULTS
2 g of amoxicillin + 1.5 mg/kg body-weight of gentamycin (IV) 30
min before tmt
1 g of amoxicillin (oral or IV) 6 h after the first dose
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN UNDER 10 YEARS OF AGE
1 g of amoxicillin + 1.5 mg/kg body-weight of gentamycin (IV) 30 min
before tmt
Amoxicillin (oral) 6 h after the first dose
ALLERGIC TO PENICILLINa
ADULTS
1 g of vancomycin (IV over 2 h) + 1.5 mg/kg body-weight of
gentamycin (IV) before tmt
CHILDREN OVER 10 YEARS OF AGE
Adult dose
CHILDREN UNDER 10 YEARS OF AGE
20 mg/kg body-weight of vancomycin (IV over 2 h) + 1.5 mg/kg body-
weight of gentamycin (IV) before tmt
min= minutes; h= hours; tmt= treatment; IV= intravenous; mg= milligrams; g= grams; kg= kilograms.
a- This protocol should also be used in patients who have received penicillin or another beta-lactam on more than 1
occasion in the previous month.
Table 9. Parenteral IE prophylaxis protocol for patients with prosthetic heart valves and/or previous episodes of IE
undergoing dental procedures under local or general anaesthesia: recommendations of the BCS and RCP (London)
(2004) [56].
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More than half of the studies published on antibiotic prophylaxis and post-dental extraction
bacteraemia have investigated the efficacy of the penicillins. The results obtained in the
majority of those studies confirmed the efficacy of these antibiotics in prevention, as bacter‐
aemia did not develop in a significant number of patients (compared with the results obtained
in patients not receiving antibiotic prophylaxis) [62,63]. However, there are fewer studies on
the effect of the prophylactic administration of other antibiotics (clindamycin, azithromycin
and cephalosporins) recommended for the prevention of post-dental extraction bacteraemia,
and their results have not established whether these antibiotics are effective [62].
STANDARD REGIMEN (ORAL)
BSAC,
2006
NOT ALLERGIC TO PENICILLIN: 3 g of amoxicillin 1 h before tmt
ALLERGIC TO PENICILLIN: 600 mg of clindamycin 1 h before tmt
UNABLE TO TAKE ORAL MEDICATIONa : 500 mg of azithromycin 1 h before tmt
AHA, 2007 NOT ALLERGIC TO PENICILLIN:
ALLERGIC TO PENICILLIN:
2 g of amoxicillin 1 h before tmt
2 g of cephalexin 1 h before tmtb
600 mg of clindamycin 1 h before tmt
500 mg of azithromycin or clarithromycin 1 h before tmt
ESC, 2009 NOT ALLERGIC TO PENICILLIN: 2 g of amoxicillin 30 min-1 h before tmt
ALLERGIC TO PENICILLIN: 600 mg of clindamycin 30 min-1 h before tmt
tmt= treatment; min= minutes; h= hours; mg= milligrams; g= grams.
a- In Great Britain, clindamycin is not available in oral suspension; b- Cephalosporins must not be administered to
subjects with immediate hypersensitivity reactions to penicillin (urticaria, angioedema or anaphylaxis).
Table 10. IE prophylaxis protocols (oral regimens) for dental procedures: recommendations of the BSAC (2006), the
AHA (2007) and the ESC (2009) [48,53,58].
For children, the BSAC recommended amoxicillin (≥10 years, adult dose; ≥5-<10 years, 1.5 g;
<5 years, 750 mg), clindamycin (≥10 years, adult dose; ≥5-<10 years, 300 mg; <5 years, 150 mg)
or azithromycin (≥10 years, adult dose; ≥5-<10 years, 300 mg; <5 years, 200 mg). For children,
the AHA recommended amoxicillin (50 mg/kg body-weight), clindamycin (20 mg/kg body-
weight), cefalexin (50 mg/kg body-weight), or azithromycin or clarithromycin (15 mg/kg body-
weight). For children, the ESC recommended amoxicillin (50 mg/kg body-weight) or
clindamycin (20 mg/kg body-weight).
For children, the AHA and ESC recommended ampicillin or amoxicillin (50 mg/kg body-
weight), clindamycin (20 mg/kg body-weight), or cephalexin, cefazolin or ceftriaxone (50 mg/
kg body-weight).
For children, the BSAC recommended amoxicillin (≥10 years, 1 g; ≥5-<10 years, 500 mg; <5
years, 250 mg) or clindamycin (≥10 years, 300 mg; ≥5-<10 years, 150 mg; <5 years, 75 mg).
A second conclusion reached by the NICE was that “It is not possible to determine the effect of
antibiotic prophylaxis on the duration of bacteraemia”. Probably influenced by the idea that
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bacteraemia secondary to dental procedures is of a transitory nature, few studies have been
published on the effect of antibiotic prophylaxis on the duration of post-dental extraction
bacteraemia [40]. On this question, the results of our research group have shown that the
prophylactic administration of oral amoxicillin (2 g) significantly reduces the prevalence of
bacteraemia at 15 minutes and 1 hour after completing dental extractions under general
anaesthesia [62]. The conclusions reached by the NICE on the lack of efficacy of antibiotic
prophylaxis for the prevention of bacteraemia following dental procedures are based on a
small volume of published scientific evidence [59]. Further research should therefore be
performed on the recommended antibiotics regimens for IE prophylaxis, analysing the
influence of the choice of antibiotic and the time and route of administration, and also on new
antibiotic protocols [40].
Antibiotic administration does carry a small risk of anaphylaxis [58]. However, no case of fatal
anaphylaxis has been reported in the literature after the oral administration of amoxicillin for
IE prophylaxis [63]. Widespread and often inappropriate use of antibiotics may result in the
emergence of resistant microorganisms [58], but the extent to which antibiotic use for IE
prophylaxis could be implicated in the general problem of resistance is unknown [64].
3.5. Antiseptics
In 1977, the AHA suggested for the first time performing disinfection of the gingival sulcus as
a complement to antibiotic prophylaxis, although they recommended caution in the use of oral
PARENTERAL REGIMEN
BSAC, 2006 NOT ALLERGIC TO PENICILLIN: 1 g of amoxicillin (IV) just before tmt or at induction of anaesthesia
ALLERGIC TO PENICILLIN: 300 mg of clindamycin (IV)a just before tmt or at induction of anaesthesia
AHA, 2007 NOT ALLERGIC TO PENICILLIN: 2 g of ampicillin (IM or IV) 30 min before tmt
ALLERGIC TO PENICILLIN: 1 g of cefazolin or ceftriaxone (IM or IV) 30 min
before tmtc
600 mg of clindamycin (IM or IV) 30 min before
tmt
ESC, 2009 NOT ALLERGIC TO PENICILLIN: 2 g of ampicillin (IV) 30 min-1 h before tmt
ALLERGIC TO PENICILLIN: 2 g of cephalexin (IV) 30 min-1 h before tmt
1 g of cefazolin or ceftriaxone (IM or IV) 30 min
before tmtc
600 mg of clindamycin (IV) 30 min-1 h before tmt
tmt= treatment; min= minutes; h= hours; IM= intramuscular; IV= intravenous; mg= milligrams; g= grams.
a- Given over at least 10 min; b- Given over 2 hours; c- Cephalosporins must not be administered to subjects with
immediate hypersensitivity reactions to penicillin (urticaria, angioedema or anaphylaxis).
Table 11. IE prophylaxis protocols (parenteral regimens) for dental procedures: recommendations of the BSAC (2006),
the AHA (2007) and the ESC (2009) [48,53,58].
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irrigators in patients considered to be at risk of IE, particularly in the presence of deficient oral
hygiene habits [44]. This approach was also adopted by the BSAC en 1982 [49], when it
recommended the application of antiseptics at the gingival margins in addition to the pro‐
phylactic administration of antibiotics prior to dental manipulations.
In 1990, the AHA recommended the application of chlorhexidine or other antiseptics (povi‐
done iodine or a combination of iodine and glycerine) for 3 to 5 minutes around the tooth—a
proposal also supported by the BSAC at that time [51]—before performing dental extractions
in patients considered to be at high risk of IE and/or with deficient oral hygiene [46]. Two years
later, the BSAC specified the form of presentation and the concentration of chlorhexidine to
be used before starting a dental procedure: 1% gel at the gingival margin or 0.2% mouthwash
for 5 minutes [52].
In the European Consensus of 1995, the application of antiseptics was once again recom‐
mended as a complementary measure in addition to antibiotic prophylaxis [54]. In its 1997
recommendations, the AHA recognised the need to use antiseptic mouthwashes (chlorhex‐
idine or  povidone iodine)  prior  to a  dental  manipulation,  although they did not  favour
their application using gingival irrigators and recommended against the continual use of
antiseptics in order to avoid the selection of resistant microorganisms [47]. Paradoxically,
in their protocols on the prevention of IE secondary to dental manipulations published in
2004, the ESC and the BCS jointly with the RCP made no reference to the use of antisep‐
tics before starting a manipulation [55,56].
In 2006, the BSAC recommended that, when possible, and in addition to the antibiotic
prophylaxis, a pre-operative mouthrinse with 0.2% chlorhexidine gluconate should be
performed, holding the antiseptic in the mouth for 1 minute [53]. In contrast, in its latest IE
guideline, the Expert Committee of the AHA did not recommend the use of antiseptic
prophylaxis before at-risk dental procedures [48].
With regard to the effect of chlorhexidine prophylaxis on the intensity and duration of
bacteraemia following dental procedures, the NICE concluded that “Chlorhexidine used as an
oral rinse does not significantly reduce the level of bacteraemia following dental procedures” [57]. This
conclusion was reached after analysis of certain studies on the efficacy of chlorhexidine
prophylaxis for the prevention of post-dental manipulation bacteraemia; those studies
presented methodological differences with respect to the dental procedure performed, the
concentration of chlorhexidine used, and the technique for applying the antiseptic solution
(mouthwash and/or irrigation). These important differences make a comparison of the results
between the different series inappropriate [59].
Very few studies have been published on the efficacy of mouth rinsing with 0.2% chlorhexidine
(recommended by the BSAC in 2006) for the prevention of post-dental extraction bacteraemia
[65]. Our research group demonstrated that initial rinsing with 0.2% chlorhexidine signifi‐
cantly reduced the duration of post-dental extraction bacteraemia [66,67]. These results allow
us to speculate that the efficacy of antibiotic prophylaxis could be improved by the simulta‐
neous application of chlorhexidine prophylaxis, although there is no scientific evidence to
support this hypothesis.
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The conclusions reached by the NICE on the lack of efficacy of antiseptic prophylaxis for the
prevention of bacteraemia following dental procedures are based on a small volume of
published scientific evidence [59]. At the present time, the controversies concerning the risk
of developing IE of oral origin, the clinical repercussions of bacteraemia of oral origin, the
efficacy of antibiotic prophylaxis and the risk-benefit and cost-benefit relationships of antibi‐
otic prophylaxis could justify the reappraisal of the need for antibiotic prophylaxis for the
prevention of IE currently being undertaken by the scientific community. Further research
should be encouraged to confirm the efficacy of the recommended chlorhexidine regimens
and to investigate new antiseptic protocols [59].
4. Conclusions
Over the past 50 years, prophylactic regimens for the prevention of IE secondary to dental
procedures have been modified but remain consensus based. The indication for prophylaxis
is now limited to patients with the highest risk of IE undergoing the highest risk dental
procedures. The most recent prophylactic protocols published by the BSAC, the AHA and the
ESC continue to recommend amoxicillin as the antibiotic of choice for oral prophylaxis. For
individuals who are allergic to penicillins, the use of clindamycin, cephalexin or another first-
generation oral cephalosporin, azithromycin or clarithromycin is recommended. However, the
NICE has adopted a drastic stance in this respect, recommending the cessation of antibiotic
prophylaxis for IE in individuals undergoing dental procedures in the United Kingdom.
Further research should be encouraged to determine the impact of this recommendation of the
NICE guideline.
All Expert Committees on IE prevention agree on the premise that “Good oral hygiene and
regular dental checkups are of particular importance for the prevention of IE of oral origin”.
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